2 results
Approved WMOWill not start
The primary objective is to determine the pharmacokinetic characteristics of galantamine after 2 single oral doses in children with Down syndrome. Secondary objectives are to evaluate safety and tolerability.
Approved WMORecruiting
The objective of the clinical investigation is to evaluate the safety and performance of the Artimis* medial meniscus prosthesis system and to demonstrate that the Artimis* medial meniscus prosthesis is able to restore the function of the natural…